SEREXIS™ 180, Defined FBS Replacement for Multiple Cell Types

Description

SEREXIS™ 180 is a serum-free, defined replacement for fetal bovine serum (FBS) in cell culture. It was developed for researchers who want to keep the performance they rely on from FBS, while moving toward a more controlled, reproducible, and serum-free system.

SEREXIS™ 180 is designed for direct substitution at standard serum concentrations and can be integrated into established FBS-based workflows without major protocol changes. It supports reliable cell growth, adherence, proliferation, viability, and morphology across multiple cell types, including A549, HeLa, MDCK, Vero, primary immune cells, keratinocytes, and fibroblasts.

With its defined and homogeneous formulation, SEREXIS™ 180 enables a decisive step beyond conventional serum supplementation: universal growth performance, without relying on FBS.

For cell types with increased lipid or fatty acid requirements, SEREXIS™ 180 can be complemented with Lipid Mix 180.

Key Benefits

• High Performance without FBS for robust growth and stable morphology
• Defined, serum-free formulation for improved reproducibility and control
• Direct switch from FBS at standard serum concentrations
• Broadly validated across cell lines and primary cells
• Workflow-friendly integration without major protocol changes
• Controlled sourcing and enhanced viral safety for sensitive applications

The SEREXIS™ product line includes three grades designed for different application requirements: 

• SEREXIS™ 180 for general cell culture workflows
• SEREXIS™ 190 Qualified for diagnostic applications and sensitive laboratory workflows requiring enhanced traceability and documentation
• SEREXIS™ 200 Biopharma Grade for vaccine manufacturing, biotech production, and highly regulated biopharma workflows requiring the highest level of documentation, regulatory compliance and viral safety support

Other unit sizes

Below you will find all other available unit sizes for this product.